Kexing Biopharm Co., Ltd.
5 clinical trials · Sponsor
◉ Watch Kexing Biopharm Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Phase I Clinical Study to Evaluate the Efficacy and Safety of GB18 Injection in Patients With Tumor Cachexia (NCT07519564) | Kexing Biopharm Co., Ltd. | 2026-06-10 |
| GB06 Phase III Trial for Pediatric Growth Hormone Deficiency (NCT07553351) | Kexing Biopharm Co., Ltd. | 2026-06-06 |
| Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy (NCT06711523) | Kexing Biopharm Co., Ltd. | 2025-01-09 |
| Human Interferon α1b Inhalation Solution Against Respiratory Syncytial Virus in Children With Lower Respiratory Tract Infections (NCT06363370) | Kexing Biopharm Co., Ltd. | 2024-03-27 |
| A Phase I Study in Healthy Participants (NCT06277167) | Kexing Biopharm Co., Ltd. | 2023-01-07 |
Track Kexing Biopharm Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.